Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $384.0 million.

  • Bristol Myers Squibb's Tax Provisions rose 28787.88% to $384.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 31010.83%. This contributed to the annual value of $2.3 billion for FY2025, which is 31010.83% up from last year.
  • Bristol Myers Squibb's Tax Provisions amounted to $384.0 million in Q4 2025, which was up 28787.88% from $919.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Tax Provisions registered a high of $919.0 million during Q3 2025, and its lowest value of -$514.0 million during Q4 2021.
  • Its 5-year average for Tax Provisions is $283.9 million, with a median of $432.0 million in 2022.
  • In the last 5 years, Bristol Myers Squibb's Tax Provisions plummeted by 14120.98% in 2023 and then surged by 28787.88% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Tax Provisions stood at -$514.0 million in 2021, then skyrocketed by 67.7% to -$166.0 million in 2022, then skyrocketed by 46.99% to -$88.0 million in 2023, then surged by 212.5% to $99.0 million in 2024, then skyrocketed by 287.88% to $384.0 million in 2025.
  • Its Tax Provisions was $384.0 million in Q4 2025, compared to $919.0 million in Q3 2025 and $460.0 million in Q2 2025.